Know Cancer

or
forgot password


Phase 4
18 Years
80 Years
Open (Enrolling by invite only)
Both
Type 2 Diabetes Mellitus, Coronary Artery Disease

Thank you

Trial Information


Inclusion Criteria:



- Thirty type 2 diabetes mellitus with stable coronary disease

- Aged 18-80 year-old

Exclusion Criteria:

- Previous underwent coronary artery bypass surgery or percutaneous angioplasty

- Under insulin injection patients

- Renal or hepatic function impairment

- Pregnant women

- Poor BP control(BP>175/105 mmHg)

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Outcome Measure:

Number of endothelial progenitor cells, endothelial function(FMD)

Outcome Time Frame:

3 months

Safety Issue:

No

Principal Investigator

Jaw-Wen Chen, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Division of Cardiology, Taipei Veterans General Hospital

Authority:

Taiwan: Institutional Review Board

Study ID:

VGHIRB 98-10-02

NCT ID:

NCT01038050

Start Date:

October 2009

Completion Date:

December 2010

Related Keywords:

  • Type 2 Diabetes Mellitus
  • Coronary Artery Disease
  • Endothelial progenitor cell
  • endothelial function(FMD)
  • Gingko Biloba Extract
  • Type 2 Diabetes mellitus
  • Stable coronary artery disease
  • Endothelial progenitor cells Numbers
  • Coronary Artery Disease
  • Myocardial Ischemia
  • Coronary Disease
  • Diabetes Mellitus
  • Diabetes Mellitus, Type 2

Name

Location